Post Profile

GW Pharmaceutical Gets Closer To Forcing FDA On Cannabis

GW Pharmaceutical announces more positive results on its epilepsy drug Epidiolex.
read more


Related Posts

Epilepsy Drug Fycompa Receives FDA Approval

Health : Medical News Today

The US Food and Drug Administration (FDA) announced on Monday that it has approved Fycompa (perampanel) tablets as an adjunctive treatment for partial onset seizures in epilepsy patients aged 12 and over. The drug, made by Eisai Inc...

New York to research cannabis for kids with severe epilepsy

News : NY Daily News

The studies will be open to 100 children and young adults whose epilepsy has resisted other treatments. The drug, Epidiolex, is not yet FDA-approved but is in trials. It will be free for qualifying patients.

FDA Could Soon Approve 1st Drug Extracted From Marijuana

Academics / General Science : Science & Health from Newser

The FDA could soon approve a marijuana-derived drug to treat a severe form of epilepsy in children, the New York Times reports. It would be the first-ever drug extracted from marijuana to be approved for use in the US. Epidiolex uti...

Biovista Inc. Announces Positive Efficacy Results In A Pre-Clinical Trial Of Its BVA-601 Repositioned Drug For Epilepsy

Health : Medical News Today

Biovista Inc. announced that BVA-601, its small-molecule drug targeting epilepsy, has shown positive results in the Kainic acid murine model of temporal lobe epilepsy. BVA-601, an existing drug that Biovista repositioned in epilepsy...

New Reports of Epidiolex(R) Efficacy and Safety Presented at the American Epilepsy Society's Annual Meeting

Health : Newswise Medical News

Three studies exploring the efficacy and safety in the development of a purified and formulated form of cannabis called Epidiolex will be presented at the American Epilepsy Society's (AES) 68th Annual Meeting.


Copyright © 2016 Regator, LLC